GROUP ONE TRADING, L.P. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 127 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$202,955
-41.5%
5,693
-34.2%
0.00%0.0%
Q1 2023$346,785
+3052.6%
8,648
+6552.3%
0.00%
Q4 2021$11,000
+266.7%
130
+333.3%
0.00%
Q3 2021$3,000
-96.5%
30
-96.7%
0.00%
Q2 2021$86,000
+681.8%
901
+828.9%
0.00%
Q1 2021$11,000
+37.5%
97
-4.0%
0.00%
Q2 2020$8,000
-84.6%
101
-91.4%
0.00%
Q1 2020$52,000
+300.0%
1,178
+288.8%
0.00%
Q4 2019$13,000
+550.0%
303
+482.7%
0.00%
Q3 2019$2,000
-33.3%
520.0%0.00%
Q2 2019$3,00052
+642.9%
0.00%
Q4 2018$0
-100.0%
7
-99.2%
0.00%
-100.0%
Q2 2018$64,000
-9.9%
829
-17.8%
0.00%0.0%
Q4 2016$71,000
+129.0%
1,009
+131.4%
0.00%
Q3 2016$31,000
-89.7%
436
-92.9%
0.00%
-100.0%
Q2 2016$300,000
+59.6%
6,125
+106.0%
0.00%
+33.3%
Q1 2016$188,000
+506.5%
2,974
+315.4%
0.00%
Q4 2014$31,000
-52.3%
716
-38.0%
0.00%
-100.0%
Q3 2014$65,000
+261.1%
1,155
+188.8%
0.00%
Q2 2014$18,0004000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders